SCHEMBL14893752

SCHEMBL14893752

COc1ccc(C2CCOC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.45
ALOX15 P16050 2/20 0.43
ALOX12 P18054 2/20 0.43
KDM1A O60341 2/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
PDE2A O00408 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27759433 0.98 DRD2 (0.44) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL27729120 0.93 DRD2 (0.41) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL9341092 0.89 DRD2 (0.43) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL8194487 0.89 DRD2 (0.51) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL5040660 0.89 KDM1A (0.46) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL20790196 0.84 KDM1A (0.48) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL31367100 0.81 KDM1A (0.46) DRD2ALOX15ALOX12KDM1AMAOA
SCHEMBL27997337 0.80 HTR2C (0.58) DRD2ADRA1A
SCHEMBL16979032 0.79 PRMT5 (0.38) ALOX15ALOX12ALDH1A1SMN1; SMN2KCNH2
SCHEMBL20408758 0.79 PRMT5 (0.38) ALOX15ALOX12ALDH1A1SMN1; SMN2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105980387-B Serine/threonine kinase inhibitor 阵列生物制药公司 2019-04-19 CN disclosed
CN-107849049-A Urea derivatives or pharmaceutically acceptable salts thereof 杏林制药株式会社 2018-03-27 CN disclosed
WO-2013062966-A2 NOVEL TRPV3 MODULATORS ABBVIE INC. (US) 2013-05-02 WO disclosed